Web Date: June 26, 2013
Supreme Court Blocks Generic Drug Lawsuits
In a major victory for the pharmaceutical industry, a divided Supreme Court ruled on June 24 that generic drug makers cannot be held liable for alleged flaws in the designs of their Food and Drug Administration-approved medications.
The 5-4 decision in Mutual Pharmaceutical v Bartlett will limit the ability of lawyers to file personal injury lawsuits in state courts against generic manufacturers, which provide about 80% . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society